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Abstract
Background: Residents of nursing homes are commonly colonized with methicillin-resistant Staphylococcus aureus
(MRSA) but there is a limited understanding of the dynamics and determinants of spread in this setting. To address
this gap, we sought to use mathematical modeling to assess the epidemic potential of MRSA in nursing homes and
to determine conditions under which non-USA300 and USA300 MRSA could be eliminated or reduced in the facilities.
Methods: Model parameters were estimated from data generated during a longitudinal study of MRSA in 6
Wisconsin nursing homes. The data included subject colonization status with strain-specific MRSA collected every
3 months for up to 1 year. Deterministic and stochastic co-colonization and single-strain models were developed
to describe strain-specific dynamics of MRSA in these facilities. Basic reproduction numbers of strain-independent
MRSA, non-USA300 and USA300 MRSA were estimated numerically. The impact of antibiotic use in the past
3 months on the prevalence of strain-specific MRSA and associated basic reproduction numbers were evaluated.
Results: Our models predicted that MRSA would persist in Wisconsin nursing homes, and non-USA300 would
remain the dominant circulating strain. MRSA eradication was theoretically achievable by elimination of MRSA-
positive admissions over the course of years. Substantial reductions in MRSA prevalence could be attained
through marked increase in clearance rates or reduction in MRSA-positive admissions sustained over years.
The basic reproduction number of strain-independent MRSA was 0.18 (95 % CI = 0.13–0.23). Recent antibiotic
use increased the prevalence of strain-specific MRSA and associated basic reproduction numbers, but was
unlikely to lead to an outbreak.
Conclusions: Based on our model, MRSA elimination from nursing homes, while theoretically possible, was
unlikely to be achieved in practice. Decolonization therapy that can sustain higher clearance rates or lower
MRSA-positive introductions over years may reduce strain-specific prevalence of MRSA in the facilities, and
antibiotic stewardship may contribute to this effort. Large-scale MRSA outbreaks were unlikely in this setting.
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Background
Methicillin-resistant Staphylococcus aureus (MRSA) is
a major cause of healthcare- and community-associated
infections [1]. Infections caused by MRSA are more
costly to treat and are associated with excess morbidity and
mortality compared to infections caused by methicillin-
sensitive strains of S. aureus [2, 3]. The dynamics of MRSA
in hospitals has been explored in a number of studies [4–6]
but its dynamics in other settings remains poorly under-
stood. Up to 50 % of nursing home residents are colonized
with MRSA [7–9] and these facilities may play an import-
ant role in regional spread of this pathogen [10, 11]. While
mathematical models have previously been used to describe
the role of nursing homes in the regional spread of MRSA
[11–14], we are aware of only one study in which intra-
facility dynamics of MRSA was modeled in nursing
homes [15]. In the latter study, mathematical modeling
was used to explain the relative contribution of health-
care workers and residents to the spread of MRSA in
nursing homes and the impact of some control strat-
egies. Notably, model inputs employed in the latter
study were based on data observed in a number of con-
texts, including non-nursing home settings.
Historically, specific strains – particularly, those
designated by the USA100 CDC pulsotype – have been
responsible for most of the MRSA observed in acute-
and long-term care settings [7, 16]. However, an
increasing number of studies suggest that community-
associated strains of MRSA (e.g., USA300 MRSA) are
becoming more common in healthcare facilities in the
U.S. [16, 17]. This is of particular concern as community-
associated strains may demonstrate a greater potential for
transmission and virulence [18–20] that, when coupled
with high levels of resident frailty, may produce more se-
vere outcomes relative to healthcare-associated strains.
Furthermore, a number of factors including recent anti-
biotic use have been implicated as risk factors for MRSA
colonization in long-term care facilities [7, 8, 21]. How-
ever, their impact on the strain-specific dynamics of
MRSA in nursing homes remains unexplained. Previously,
we used Markov chain models to determine the ultimate
distribution of residents colonized with non-USA300 and
USA300 and to assess the influence of MRSA strain-type
and potential risk factors on MRSA acquisition in nursing
homes [22]. We found that non-USA300 strains would re-
main dominant in nursing homes. Among the candidate
risk factors considered in our study, antibiotic use within
the past 3 months was the only one to significantly in-
crease the acquisition rates of strain-independent and
non-USA300 MRSA.
The transmission dynamics of non-USA300 and USA300
MRSA in nursing homes remains largely unexplained. For
instance, while nursing homes are known as reservoirs of
MRSA [10], the risk of MRSA outbreak and the prospects
of MRSA reduction or elimination in this setting have
not been well-understood. Furthermore, the effect of
resident-specific characteristics, such as previous anti-
biotic use, and facility-specific characteristics, such as
admission and discharge of colonized, on epidemic po-
tential of MRSA have not been established. In this
work, we focused on studying the epidemic potential of
MRSA and the relative merits of interventions to re-
duce or eliminate MRSA from nursing home facilities
using compartmental and stochastic modeling ap-
proaches. It should be noted that we focused on the
U.S. nursing homes most of which provide a mixture of
post-acute, rehabilitative and domiciliary services to
residents that are generally elderly and require ongoing
skilled nursing care. The specific aims of this study
were: (1) to evaluate the impact of selected measures
on the prevalence of strain-specific MRSA over time
and to determine the conditions for MRSA elimination
from study nursing homes; (2) to assess the epidemic
potential of MRSA and its sensitivity to changes in acqui-
sition and clearance rates, and admission and discharge of
colonized; (3) to assess the impact of antibiotic use in the
previous 3 months on the prevalence of strain-specific
MRSA and its outbreak potential.
Methods
Overview
Deterministic compartmental models were developed to
describe the transmission dynamics of MRSA in the
study nursing homes. Stochastic models were subse-
quently simulated to assess the impact of randomness
on predicted outcomes. The study was reviewed and ap-
proved by the Health Sciences Institutional Review
Board of the University of Wisconsin-Madison.
Data
All model inputs, including model parameters, were de-
rived from data collected during a longitudinal study of
antibiotic resistance in six nursing homes in Wisconsin
[23]. MRSA surveillance cultures were collected from
multiple anatomical locations of each subject at baseline
and every 3 months thereafter for a period of up to 1
year [23]. The subject’s MRSA status was considered
non-evaluable if a culture from any of the routinely
screened body sites was missing. Thus, 446 out of 449
subjects contributed evaluable observations to this study.
It should be noted that the baseline assessment was not
evaluable for two subjects with multiple observations
over the study period [22]. Their assessment at 3 months
was considered as baseline assessment for the purpose of
this study. Data on antibiotic use in the previous 3
months, dichotomized into No or Yes, were abstracted
from health records at the time surveillance cultures were
performed. Most of the antibiotics were administered
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orally and were prescribed for treating urinary tract
infection. About 15 % of antibiotics, including sulfon-
amides and tetracyclines, may have possessed anti-
MRSA activity. The data from the six study nursing
homes were merged to improve the precision of re-
sults; that is, the study outcomes are representative of
the hypothetical “combined” Wisconsin nursing home.
Facility-level differences in characteristics of these
nursing homes and MRSA colonization trends in indi-
vidual facilities were described elsewhere [22, 23].
Model overview
Strain-specific transmission was studied in a co-
colonization model (i.e., a model that describes
colonization with non-USA300, USA300 and simul-
taneous colonization with both strains of MRSA)
which was considered in both deterministic and sto-
chastic frameworks (Fig. 1a). Deterministic models
provide a simple mechanism for describing the dy-
namics of MRSA in the population on average and
for assessing the outbreak potential of the pathogen.
However, predictions from deterministic models may
lack accuracy when applied to populations with few
subjects in either compartment, like ours, and do not
account for variability in the predicted outcomes. Subse-
quently, to enhance our understanding of the transmission
mechanism, a stochastic co-colonization model was
implemented.
The co-colonization model in a deterministic frame-
work was used to assess the relative merits of selected
interventions, the outbreak potential of MRSA, and the
impact of antibiotic use in the past 3 months on MRSA
prevalence and a possibility of outbreak. To evaluate the
relative contribution of each strain-type to the outbreak
potential of MRSA, single-strain models in a determinis-
tic framework were also considered (Fig. 1b).
In all models, the number of contacts between resi-
dents was assumed to be independent of the size of
the nursing home (this assumption regarding the
underlying structure of contacts is referred to as
frequency-dependent transmission or mass action
[24]). Colonization was assumed to occur via random
mixing between colonized and non-colonized residents.
No distinction was made between colonized and in-
fected. The entire dataset was used to implement every
model. The computation was performed in R, version
3.1.0 and higher [25].
Transmission dynamics of MRSA and impact of selected
measures on its prevalence over time
In the co-colonization model, the study population was
divided into four mutually exclusive compartments:
susceptible to any MRSA (S), colonized with non-
USA300 only (I1), colonized with USA300 only (I3) and
co-colonized with both strains (Ib) (Fig. 1a). In the de-
terministic model, the total population size, N, was
assumed to stay constant over time to reflect the fixed
nursing home capacity and 100 % bed occupancy: N =
S(t) + I1(t) + I3(t) + Ib(t). In the stochastic model, the
population size was assumed not to exceed N. The
constant N was estimated as the number of subjects
with at least one evaluable observation over the study
period. The model parameters and initial conditions
are described in detail in Table 1. The probability of
an admitted resident to be colonized, λ, was estimated
as the proportion of colonized residents at baseline.
The discharge rate of colonized and non-colonized
residents, γI and γS, were estimated as inversely pro-
portional to the length of stay for colonized and
non-colonized, respectively. The length of stay was
calculated as an average period of time between
a
b
Fig. 1 Model diagrams. Compartmental models which describe
transmission dynamics of MRSA in nursing homes. The rectangles
represent cohorts of residents; the arrows represent inflow to and
outflow from each compartment due to disease transmission,
clearance, admission or discharge, including death. a Co-colonization
model (model parameters are described in Table 1), S is the cohort of
residents susceptible to any MRSA; I1 is the cohort of residents
colonized with non-USA300 and susceptible to USA300; I3 is the
cohort of residents colonized with USA300 and susceptible to
non-USA300; Ib is the cohort of residents colonized with both MRSA
strains; b Model for colonization with a single MRSA strain-type, either
non-USA300 or USA300 MRSA, where λ*, γI*, b*n, gn*, and I* represent
the corresponding parameters specific to each single strain model,
non-USA300 or USA300
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residents’ admission dates and their baseline examina-
tions, taken across the six facilities. The discharge rates
were assumed to include the discharge from the facility
and death from any cause. The admission rate (Λ) was
assumed to equal the discharge rate at any time t: Λ(t)
= γSS(t) + γII(t), where I(t) = I1(t) + I3(t) + Ib(t). The acquisi-
tion and clearance rates for non-USA300 (b1n and
gn1) and USA300 (b3n and gn3) were estimated as
transition rates between non-colonized and colonized
with the corresponding strain when fitting 2 two-
state continuous-time Markov chain models [26]
described elsewhere [22]. The states of these models
represented non-colonized and colonized with a sin-
gle MRSA strain irrespective of colonization with the
other strain. The rates represent relative frequency
per 3 months. The R package msm (version 1.3 or
above) was used to fit each model to the entire data-
set [25, 27]. Acquisition and clearance of one strain
was assumed to be independent from carriage of the
other strain. The following system of non-linear dif-
ferential equations described the deterministic co-
colonization model:
Table 1 Parameters and initial occupancy for the co-colonization model
Description Symbol Value (95 % CI) Estimated or Observed
Initial occupancy in each compartment
Number of residents susceptible to any MRSA S 350 observed
Number of residents colonized with non-USA300 I1 79 observed
Number of residents colonized with USA300 I3 14 observed
Number of residents co-colonized with non-USA300 and USA300 Ib 3 observed
Total number of residents N 446 observed
Model Parameters
Probability of admission of MRSA-colonized residents λ 0.215 estimated
Discharge rate of susceptibles (per 3 months) γS 0.101 estimated
Discharge rate of MRSA-colonized (per 3 months) γI 0.074 estimated
Proportion of residents colonized with non-USA300 at baseline w1 0.823 observed
Proportion of residents colonized with USA300 at baseline w3 0.146 observed
Proportion of residents co-colonized with both strains at baseline wb 0.031 observed
Acquisition rate for non-USA300a b1n
- generalb 0.029 (0.022, 0.038) estimated
- w/o ABc 0.020 (0.014, 0.030) estimated
- with ABd 0.042 (0.030, 0.061) estimated
Acquisition rate for USA300a b3n
- generalb 0.006 (0.004, 0.011) estimated
- w/o ABc 0.004 (0.002, 0.010) estimated
- with ABd 0.009 (0.005, 0.019) estimated
Clearance rate for non-USA300a gn1
- generalb 0.116 (0.088, 0.152) estimated
- w/o ABc 0.125 (0.086, 0.179) estimated
- with ABd 0.107 (0.074, 0.163) estimated
Clearance rate for USA300a gn3
- generalb 0.137 (0.082, 0.228) estimated
- w/o ABc 0.155 (0.079, 0.328) estimated
- with ABd 0.125 (0.064, 0.266) estimated
AB, antibiotic use in the past 3 months
aRelative frequency per 3 months
bThe rate irrespective of antibiotic use in the past 3 months
cThe rate corresponding to No level of antibiotic use in the past 3 months
dThe rate corresponding to Yes level of antibiotic use in the past 3 months
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dS
dt
¼ 1−λð ÞΛ−b1n I1 þ Ibð Þ⋅ SN −b3n I3 þ Ibð Þ⋅
S
N
þ gn1I1 þ gn3I3−γSS;
dI1
dt
¼ w1λΛþ b1n I1 þ Ibð Þ⋅ SN −b3n I3 þ Ibð Þ⋅
I1
N
−gn1I1 þ gn3Ib−w1γI I;
dI3
dt
¼ w3λΛþ b3n I3 þ Ibð Þ⋅ SN −b1n I1 þ Ibð Þ⋅
I3
N
−gn3I3 þ gn1Ib−w3γI I;
dIb
dt






















The stability of endemic and disease-free equilibria
[24] (the state of the system when no changes are ob-
served over time, while the disease is present or absent,
respectively) was established by dynamically running the
system of differential Eqs. (1) with the initial conditions
(Table 1) to steady-state using the rootSolve package in R
environment [25]. The steady-state tolerance was set to
the nearest hundredth.
The sensitivity analysis of the MRSA prevalence to the
estimated parameters of the model was performed. The
changes in the point prevalence of non-USA300 and
USA300 MRSA over time were predicted for the values
of admission prevalence, (λ) between 0 and 0.5 with step
0.1. This range includes and exceeds the admission
prevalence of MRSA reported in other studies [9, 15, 16].
The ranges for the sensitivity analysis of discharge rates of
colonized and non-colonized (γI and γS) were chosen
based on the respective interquartile ranges of resident
length of stay across the facilities. Thus, discharge rates of
0.05-1.05 (step 0.2) for colonized and 0.05-0.55 (step 0.1)
for non-colonized were employed in the sensitivity ana-
lysis. Acquisition rates (b1n and b3n) up to three times as
high as the estimate for non-USA300 and 10 times higher
than the estimated rate for USA300 were considered for
the sensitivity analysis (that is, 0–0.12 (step 0.02) for
non-USA300 and 0–0.06 (step 0.01) for USA300). Clear-
ance rates (gn1 and gn3) between the values twice lower
and twice higher than estimated rates were employed in
the sensitivity analysis (that is, 0.058–0.232 (step 0.029)
for non-USA300 and 0.068–0.278 (step 0.042) for
USA300).
The parameters of the deterministic co-colonization
model (1) were altered to assess their impact on the
strain-specific point prevalence of MRSA in the follow-
ing scenarios:
– Scenario 1: elimination of intra-facility MRSA
cross-transmission (b1n = b3n = 0; Table 1),
– Scenario 2: doubling of the strain-specific MRSA
clearance rates (2×[gn1] and 2×[gn3]; Table 1),
– Scenario 3: elimination of all MRSA-positive
admissions (λ = 0; Table 1),
– Scenario 4: elimination of a half of MRSA-positive
admissions (λ/2; Table 1).
Elimination of intra-facility cross-transmission (Sce-
nario 1) could theoretically be achieved through active
surveillance and adherence to more aggressive forms of
contact precautions than the ones commonly employed
in nursing homes or decolonization therapy [28, 29]. It
should be noted that by cross-transmission we understood
transition from being non-colonized to colonized with
non-USA300 or USA300 strain of MRSA, or transition
from colonized with non-USA300 or USA300 to co-
colonized with both strains. Decolonization therapy was
shown to increase MRSA clearance rates (Scenario 2) in
nursing homes [28]. Elimination or reduction in MRSA-
positive admissions (Scenarios 3 and 4) could be achieved
through active surveillance at admission coupled with
decolonization therapy [28]. This intervention was im-
plemented by some hospitals, and positive results were
reported [30, 31]. Furthermore, reducing MRSA preva-
lence and transmission in the community and health-
care settings that transfer patients to nursing homes,
including acute-care hospitals, may reduce the admis-
sion prevalence of MRSA in nursing home facilities.
The prevalence of MRSA under each scenario may help
to inform infection control in nursing homes.
The stochastic co-colonization model was a continuous-
time Markov chain model and was simulated using
Gillspie’s algorithm [32, 33]. The possible state transi-
tions of the model and their respective rates are pre-
sented in Appendix Table A1. The model was simulated
1000 times, and the mean of the 1000 simulations was
calculated.
Assessing epidemic potential of MRSA
The basic reproduction number, R0, was used as a
threshold to assess the epidemic potential of MRSA in
the study nursing homes. In the context of our study, R0
represented the expected number of secondary cases of
colonization with strain-independent MRSA caused by a
single MRSA-colonized resident in a totally susceptible
population [34]. A value of R0 greater than 1 would pre-
dict the spread of MRSA in the population over time
and imply that MRSA may become epidemic. The basic
reproduction number was estimated by the Next Gener-
ation Method [34], using pertinent parameters from
Table 1. Standard errors and 95 % confidence intervals
(CI) around point estimates were computed by means of
bootstrapping with 1000 resampling runs and assuming
approximate normality of standard errors [35].
To evaluate the relative contribution of non-USA300
and USA300 strains to the epidemic potential of MRSA,
their basic reproduction numbers (R01 and R03, respect-
ively) were estimated from two single-strain models
(Fig. 1b). In the single-strain models, the population was
divided into non-colonized (S) and colonized with the
strain of interest (I*), where both S and I* may have
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contained subjects colonized with the other strain (i.e.,
when calculating R01, a resident colonized with USA300
but free of non-USA300 would be considered non-
colonized). Each single-strain model was described by
the system of differential equations:
dS
dt













where λ*, γI*, b*n, gn*, and I* represent the respective
parameters specific to each single strain model, non-
USA300 or USA300. For non-USA300 model, the
probability of admitting colonized (λ*) was estimated
to be 0.184, and the discharge rate of colonized (γI*)
was 0.081. For USA300 model, these parameters were
0.038 and 0.046, respectively. These strain-specific pa-
rameters were calculated using the same procedure as
the respective strain-independent parameters from
Table 1. The Next Generation Method [34] was used
to obtain R01 and R03, and 95 % confidence intervals
were calculated by bootstrapping with 1000 resam-
pling runs [35].
For the co-colonization model (Fig. 1a), the basic
reproduction number was examined over the space of
acquisition and clearance rates of non-USA300 and
USA300 within their 95 % CI’s (Table 1). For that pur-
pose, the 95 % CI’s for the four rates (Table 1) were par-
titioned into steps of size 0.001, and an R0 was
recalculated for each possible combination of the rates.
Furthermore, the sensitivity of R0 to the acquisition and
clearance rates, discharge rate of colonized, and prob-
ability of MRSA-positive admissions was assessed in a
one-way sensitivity analysis in which each parameter
was varied between 0 and 1 while keeping all other
model parameters at their fixed values.
Impact of antibiotic use in the previous 3 months
The co-colonization model (Fig. 1a) with antibiotic-
specific acquisition and clearance rates (Table 1) was
used to estimate the changes in the point prevalence of
strain-specific MRSA over time for each level of recent
antibiotic use (Yes and No). The hypothetical “best case”
and “worst case” scenarios were examined by using the
combinations of upper and lower bounds of the 95 %
CI’s around antibiotic-specific acquisition and clearance
rates (Table 1). The “worst case” scenarios assumed high
acquisition and low clearance, while the “best case” sce-
narios were low acquisition and high clearance. For each
level of antibiotic use, the basic reproduction numbers
R0, R01 and R03 were estimated from the co-colonization
model (Fig. 1a) and respective single-strain models
(Fig. 1b) in which antibiotic-specific acquisition and
clearance rates were used (Table 1).
Results
Our deterministic model predicted that under the ob-
served conditions, MRSA would remain endemic in our
“combined” nursing home over the long run, and non-
USA300 would remain the dominant circulating strain
(solid line in Fig. 2). The equilibria were stable. After
20 years, 11 %, 1.5 %, and less than 1 % of residents were
predicted to be colonized with non-USA300, USA300
and co-colonized with both MRSA strains, respectively.
The outcomes of the stochastic simulations highlighted
the variability in the MRSA dynamics over time, but
trends, in aggregate, were qualitatively similar to the
ones of the deterministic model (Appendix Figures A1,
A2, and A3).
Elimination of intra-facility cross-transmission had a
modest impact on the predicted prevalence of non-
USA300 and very little impact on the predicted preva-
lence of USA300 and co-colonized with both strains
(Scenario 1 in Fig. 2). Greater reductions in the preva-
lence of MRSA could be achieved through doubling
clearance rates or reducing the probability of admission
of colonized two-fold (Scenarios 2 and 4 in Fig. 2). The
only scenarios under which MRSA extinction could be
achieved were through elimination of all MRSA-
positive admissions (Scenario 3 in Fig. 2) or through
selective discharge of colonized residents (Appendix
Figure A4). It should be noted, however, that predicted
reductions or elimination of MRSA would take years
even if any of these unlikely conditions could be
achieved.
The point prevalence of non-USA300 and USA300
was sensitive to the admission prevalence of MRSA, λ
(Fig. 3a-b). However, the point prevalence of either
strain decreased over time for any realistic values of the
admission prevalence (admission prevalence as high as
31 % was reported in one nursing home in California
[9] but generally lower values were observed [9, 16]).
Growth of the strain-specific point prevalence of MRSA
over time was predicted for higher values of discharge
rates of non-colonized, γS, considered in the sensitivity
analysis (Fig. 3c-d). The point prevalence of both non-
USA300 and USA300 decreased for the range of dis-
charge rates of colonized, γI, employed in the sensitivity
analysis (Fig. 3e-f ). Three-fold increase of non-USA300
and 10-fold increase of USA300 acquisition rates (b1n
and b3n, respectively) were predicted to yield decreased
point prevalence of the respective strain over time
(Fig. 3g-h). Likewise, the point prevalence of either
strain was not expected to grow over time if the re-
spective clearance rate (gn1 and gn3) was twice lower
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than the estimate (Fig. 3i-j). The prevalence of either
strain was even less sensitive to the changes in the rates
of the other strain.
The basic reproduction number for strain-independent
MRSA was estimated to be substantially below the
threshold of 1 (R0 = 0.18; 95 % CI = 0.13 - 0.23) (Table 2).
The value of R0 did not exceed 0.25 for any combination
of acquisition and clearance rates within their 95 % CI’s.
The changes in R0 within the 95 % CI’s for the pairs of ac-
quisition and clearance rates are illustrated in Appendix
Figure A5. The basic reproduction number for non-
USA300 (R01 = 0.16; 95 % CI = 0.11 - 0.21) was substan-
tially higher than the one for USA300 (R03 = 0.04; 95 % CI
= 0.01 - 0.06) (Table 2). The sensitivity analysis (Fig. 4)
suggested that R0 was most sensitive to acquisition rates.
Antibiotic use in the past 3 months was associated
with non-significant increases in the point prevalence
of non-USA300 and USA300 in the nursing home
(Fig. 5). The predicted prevalence of non-USA300
among antibiotic-exposed residents was consistently
higher than among unexposed residents over 20 years
(Fig. 5a). This difference was less pronounced for
USA300 and co-colonized residents (Figs. 5b, c). The
estimated value of R0 (Table 2) was higher among
those who used antibiotics in the past 3 months (R0 =
0.28; 95 % CI = 0.16 - 0.40) compared to those who did
not (R0 = 0.12; 95 % CI = 0.07 - 0.17) although this differ-
ence was not statistically significant at a 95 % confidence
level. The value of R01 (Table 2) was significantly higher
for those with the recent history of antibiotic use (R01 =
0.24; 95 % CI = 0.15 - 0.34) than for the ones without it
(R01 = 0.11; 95 % CI = 0.06 - 0.15).
Discussion
Residents of nursing homes are commonly colonized
with MRSA and there is increasing recognition that
these facilities influence patterns of MRSA within other
healthcare facilities in the same region [36, 37]. Math-
ematical modeling has been extensively used to under-























































































Fig. 2 Distribution of subjects colonized with strain-specific MRSA
over time under selected scenarios derived from the deterministic
model. The curve Observed represents the percent of colonized
subjects over time based on the observed data; Scenario 1 shows
the percent of colonized subjects under the assumption of no
intra-facility cross-transmission; Scenario 2 reflects the percent of
colonized subjects when MRSA clearance rates are increased two-fold;
Scenario 3 represents the percent of colonized over time when all
positive MRSA admissions are eliminated; Scenario 4 shows the percent
of colonized over time when a half of all positive MRSA admissions are
eliminated. a Percent colonized with non-USA300; b Percent colonized
with USA300; c Percent co-colonized with non-USA300 and USA300
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Fig. 3 (See legend on next page.)
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spread between healthcare facilities within the same re-
gion [4, 6, 12, 13]. In contrast, attempts to employ math-
ematical modeling to gain a better understanding of the
dynamics of MRSA within the nursing home context re-
main sparse. The current study advances our knowledge
about the prospects of reducing or eliminating MRSA
from nursing homes and, conversely, the potential for
these facilities to experience a MRSA outbreak. It also
examines the impact of recent antibiotic use on the
prevalence of MRSA and its outbreak potential.
Our study suggests that elimination of MRSA from
nursing homes in the U.S. is highly unlikely under any
reasonable conditions. Based on our model, eradication
of MRSA could be eventually achieved in nursing facil-
ities if all MRSA-positive admissions were eliminated
over a prolonged period of time (years). This intuitive
finding is similar to the finding of the other modeling
study [15], which concluded that MRSA would persist
in nursing homes for as long as colonized residents
continue to enter the facilities. Elimination of MRSA
introductions could theoretically be achieved through
active surveillance, particularly when coupled with ef-
fective social distancing interventions or decolonization
therapy. Nevertheless, the likelihood of achieving these
outcomes in actual practice seems remote for a variety
of reasons.
Surprisingly, elimination of intra-facility cross-transmission
had a minimal impact on the predicted prevalence of
strain-specific MRSA over years. While acquisition
rates depend on the intrinsic characteristics of the
pathogen, they may also be influenced by colonization
pressure [38] and mixing patterns among residents and
between residents and staff within the facilities. Several
studies have demonstrated that active surveillance, par-
ticularly when combined with social distancing mea-
sures, can be effective in reducing MRSA prevalence in
hospitals and nursing homes [29, 39]. However, the
findings of our study suggest that this approach would
be of limited utility in nursing homes. This is particu-
larly germane in the long-term care setting where social
interactions between residents are considered a goal of
care.
Two-fold increase in strain-specific clearance rates
or two-fold decrease in MRSA-positive admissions,
which could be achieved through the use of
decolonization therapy [40], was associated with more
substantial reductions in strain-specific prevalence of
MRSA if sustained for several years. However, limita-
tions in currently available de-colonization interven-
tions may be a significant barrier to this reduction
approach. Intra-nasal mupirocin has been shown to
reduce (but not to eliminate) MRSA carriage in several
nursing home studies [28, 41]. Coupled with imperfect
surveillance for MRSA [7, 42, 43], these reductions
may be more moderate than expected. Moreover, these
studies demonstrated that de-colonization in most
residents was transient and associated with the emer-
gence of resistance [41]. Consequently, the effective-
ness of using mupirocin to reduce the prevalence of
MRSA in nursing homes over the long run may be
limited.
Taken together, our findings suggest that MRSA elim-
ination in nursing homes is unlikely but reductions in
the prevalence of MRSA are theoretically achievable,
(See figure on previous page.)
Fig. 3 Sensitivity of the point prevalence of MRSA to the estimated parameters. The solid black lines represent the strain-specific point prevalence
of MRSA given the estimated model parameter (Table 1). The grey lines represent the point prevalence of MRSA calculated for various values of
the parameter; these values are displayed as labels above or below the lines. a Sensitivity of the prevalence of non-USA300 to MRSA admission
prevalence, λ; b Sensitivity of the prevalence of USA300 to MRSA admission prevalence, λ; c Sensitivity of the prevalence of non-USA300 to
discharge rates of non-colonized, γS; d Sensitivity of the prevalence of USA300 to discharge rates of non-colonized, γS; e Sensitivity of the
prevalence of non-USA300 to discharge rates of colonized, γI; f Sensitivity of the prevalence of USA300 to discharge rates of colonized, γI;
g Sensitivity of the prevalence of non-USA300 to acquisition rates of non-USA300, b1n; h Sensitivity of the prevalence of USA300 to acquisition
rates of USA300, b3n; i Sensitivity of the prevalence of non-USA300 to clearance rates of non-USA300, gn1; j Sensitivity of the prevalence of
USA300 to clearance rates of USA300, gn3
Table 2 Basic reproduction number for strain-independent and strain-specific MRSA
Basic Reproduction Number Point Estimate (95 % CI)
General (irrespective of AB) w/o AB with AB
Strain-independent MRSA, R0 0.18 (0.13, 0.23) 0.12 (0.07, 0.17) 0.28 (0.16, 0.40)
Non-USA300, R01 0.16 (0.11, 0.21) 0.11 (0.06, 0.15) 0.24 (0.15, 0.34)
USA300, R03 0.04 (0.01, 0.06) 0.02 (0.00, 0.05) 0.05 (0.02, 0.09)
AB, antibiotic use in the past 3 months
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particularly through interventions that accelerate the
rate of resident de-colonization or reduce the admission
prevalence of MRSA. Nevertheless, our models predict
that these interventions would need to be sustained over
a period of years in order to have a demonstrable effect
on observed patterns of colonization.
An MRSA outbreak in the study nursing homes as
quantified by an R0 value greater than 1, while theoretically
possible, was only achievable under extraordinary circum-
stances (e.g., multi-fold increase in MRSA acquisition
rates). However, minor strain-specific outbreaks were ob-
served during a number of realizations of the stochastic
model. Collectively, these findings suggest that while major
MRSA outbreaks are unlikely to take place in nursing
homes, minor outbreaks may occasionally occur. The basic
reproduction number of non-USA300 appeared to be sig-
nificantly higher than that of USA300 suggesting a higher
epidemic potential of non-USA300 strain of MRSA. Fur-
thermore, while recent antibiotic exposure elevated epi-
demic potential of MRSA, it was unlikely to lead to an
outbreak. More research is needed to study factors that
may lead to MRSA outbreaks in nursing homes and to
evaluate possible outbreak prevention strategies.
The limitations of our study are primarily influenced
by the scarcity of data, particularly for USA300 MRSA,
and modeling assumptions. For example, while individ-
ual nursing homes may differ in transmission dynamics
of MRSA, we combined the data from the six facilities
due to its paucity in individual facilities. Hence, the re-
sults would be applicable to a hypothetical “combined”
nursing home. On the other hand, in our previous work
we found that the patterns of predicted prevalence at
steady state in most facilities mirrored the patterns for
pooled data [22].
The standard assumption of random mixing among
residents may not be realistic in nursing homes where
residents tend to socialize selectively, may share a room,
may have limited mobility or be bed-bound. Even
though our homogeneous-mixing model predicted that
MRSA outbreaks were unlikely in the study nursing
homes, they may actually be occurring in subgroups of
residents (e.g., in subgroups with substantially higher
contact rates between colonized and susceptibles). Our
simplifying assumption of constant acquisition and
clearance rates of strain-specific MRSA may not be true
in nursing homes. The reasons include the variability in
contact patterns among residents and between residents
and staff, differences in exposure to potential risk fac-
tors, colonization pressure [38] and the effect of super-
spreaders [44]. Furthermore, we assumed that transmis-
sion and acquisition of either strain was independent of
colonization status with the other strain, while there is
no evidence in favor or against this assumption. More-
over, our models did not account for MRSA transmis-
sion through hands of health care workers which may
play a role in the spread of MRSA in nursing homes
[15, 45]. Additionally, the admission prevalence of
MRSA that was assumed to be constant in our models
may vary over time. The reasons include differences in
the prevalence of MRSA colonization among residents
admitted from hospitals and the community.
A number of model parameters were not readily avail-
able in our dataset and were estimated from our data.
Thus, the point prevalence of MRSA at baseline was
used as admission prevalence, though these values may
differ in practice. One study of ten nursing homes in
California found that the point prevalence of MRSA,
while being significantly higher, correlated well with the
admission prevalence in the study facilities [9]. MRSA
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Fig. 4 Sensitivity of the basic reproduction number, R0, to changes
in acquisition and clearance rates, one at a time. The horizontal
dotted lines highlight the R0 threshold value of 1. The stars display
the actual value of R0, that is, the value calculated using model
parameters (Table 1). a Sensitivity of R0 to acquisition rates of non-
USA300 (b1n) and USA300 (b3n); b Sensitivity of R0 to clearance rates
of non-USA300 (gn1) and USA300 (gn3)
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admission prevalence reported in this study varied be-
tween 8 % and 31 %, with half of the facilities admitting
21 % or more of MRSA colonized [9]. Our estimate of
0.215 is comparable with MRSA admission prevalence
reported in that study, but is higher than those in other
studies [15, 16]. It is also likely to be an overestimate for
our study facilities. If so, our results may be a worse
prognosis than reality. On the other hand, if the length
of stay for non-colonized is lower than our estimate,
then our prognosis may be too optimistic. Based on our
sensitivity analysis, realistic changes in other estimated
parameters are unlikely to substantially alter the pre-
dicted prevalence. Given a limited knowledge of MRSA
patterns in nursing homes, our study is an important
step in continuum research that aims at improving our
understanding of the dynamics of strain-specific MRSA
in nursing homes.
To our knowledge, our study is the first modeling
study that sought to assess the epidemic potential of
strain-specific MRSA, to evaluate the conditions for
MRSA elimination, and to examine the relative merits of
selected reduction scenarios of stain-specific MRSA in
nursing homes. More research is needed to assess other
potential conditions for reducing MRSA colonization in
nursing homes and evaluate their cost-effectiveness.
Modeling techniques that accommodate heterogeneity
of mixing patterns among residents may be a valuable
tool in this effort. Furthermore, examining the associa-
tions between the candidate risk factors for MRSA
colonization and MRSA pulsotypes differentiated at a
higher strain similarity threshold may aid in better
informing the choice of interventions aimed at reducing
the burden of MRSA in nursing homes in the U.S.
Conclusions
We used mathematical modeling to assess the out-










































































Fig. 5 Impact of antibiotic use in the past 3 months on MRSA point
prevalence and epidemic potential. Black lines represent the point
prevalence of colonized who used antibiotics in the past 3 months,
and grey lines show the point prevalence of those who did not.
Solid lines denote the distribution of colonized when MRSA acquisition
and clearance rates were set at the respective point estimates
(Table 1). Dashed lines represent the distribution of colonized in
hypothetical scenarios which employed the combinations of
upper and lower bounds of the 95 % CI’s of the respective acquisition
and clearance rates. Thus, the dashed lines above the corresponding
solid lines represent scenarios with high acquisition rates and low
clearance rates, while dashed lines below the corresponding solid lines
show scenarios with low acquisition and high clearance rates.
a Distribution of colonized with non-USA300; b Distribution of
colonized with USA300; c Distribution of co-colonized with non-USA300
and USA300
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homes and to evaluate conditions for eliminating or
reducing MRSA in this setting. Our study suggests
that despite the presence of USA300 strains in a
number of the study nursing homes, non-USA300
will remain the dominant circulating MRSA strain in
Wisconsin facilities. We found that MRSA elimin-
ation from the U.S. nursing homes, while theoretic-
ally possible, is unlikely to be achieved in practice.
Marked reductions in the strain-specific MRSA in this set-
ting may be attained by using active surveillance coupled
with decolonization therapy that can sustain substan-
tially higher clearance rates or reductions in MRSA
admission prevalence over years, and antibiotic stew-
ardship may contribute to this effort. Eliminating
intra-facility cross-transmission had little impact on
the predicted prevalence of MRSA in our models.
Despite the recent emergence of novel MRSA
strains, including USA300, our models predicted that
large-scale outbreaks were unlikely in the nursing
home setting.
Table 3 Transitions between the states of the stochastic model
Event Transition Rate Constant Rate
Admission of susceptible residents ∅→ S (1 − λ)Λ (1 − λ)Λ
Discharge of susceptible residents S→∅ γS γSS
Admission of colonized with non-USA300 ∅→ I1 (w1λ)Λ (w1λ)Λ
Discharge of colonized with non-USA300 I1→∅ w1γI (w1γI)I










Clearance of colonized with non-USA300 I1→ S gn1 gn1I1
Admission of colonized with USA300 ∅→ I3 (w3λ)Λ (w3λ)Λ
Discharge of colonized with USA300 I3→∅ w3γI (w3γI)I










Clearance of colonized with USA300 I3→ S gn3 gn3I3
Admission of co-colonized with both strains ∅→ Ib (wbλ)Λ (wbλ)Λ
Discharge of co-colonized with both strains Ib→∅ wbγI (wbγI)I




















Clearance of co-colonized from USA300 Ib→ I1 gn3 gn3Ib
Clearance of co-colonized from non-USA300 Ib→ I3 gn1 gn1Ib
Appendix
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Fig. 6 Counts of strain-specific MRSA over time in the hypothetical “combined” nursing home based on stochastic and deterministic models.
Solid black lines represent means of the 1000 realizations of the stochastic model; grey lines show the first 20 individual runs of the stochastic
model. Dashed black lines are counts derived from the deterministic model. a counts of subjects susceptible to any MRSA strain; b counts of
subjects colonized with non-USA300 and susceptible to USA300; c counts of subjects colonized with USA300 and susceptible to non-USA300;
d counts of subjects co-colonized with non-USA300 and USA300




Fig. 7 Distribution of subjects colonized with non-USA300 over time in selected scenarios. The black dotted lines represent the percent colonized
with non-USA300 derived from the deterministic model. The black solid line represents the mean of 1000 stochastic simulations, and the grey
solid lines show the first 20 out of 1000 individual simulations. a Predictions based on observed data; b Predictions under the assumption of no
intra-facility cross-transmission of MRSA; c Predictions under the assumption of two-fold increase of clearance rates of MRSA; d Predictions when
the influx of colonized into the facility is prevented; e Predictions when the influx of colonized into the facilities is reduced two-fold
















































































Fig. 8 Counts of strain-specific MRSA over time in the hypothetical “combined” nursing home based on the stochastic model. Solid black line rep-
resents the mean of the 1000 realizations of the stochastic model; grey lines show all 1000 individual runs of the stochastic model. a counts of
subjects colonized with non-USA300 and susceptible to USA300; b counts of subjects colonized with USA300 and susceptible to non-USA300; c
counts of subjects co-colonized with non-USA300 and USA300
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Fig. 9 Distribution of subjects colonized with strain-specific MRSA over time under the hypothetical assumption of selective discharge of
colonized residents. The curves non-USA300, USA300 and co-colonized represent the percent of subjects colonized with non-USA300,














































Fig. 10 Basic reproduction number of strain-independent MRSA, R0, within 95 % confidence intervals of estimated acquisition and clearance rates
of strain-specific MRSA. a R0 within 95 % CI’s of acquisition rates of non-USA300 (b1n) and USA300 (b3n); b R0 within 95 % CI’s of clearance rates of
non-USA300 (gn1) and USA300 (gn3); c R0 within 95 % CI’s of acquisition and clearance rates of non-USA300 (b1n and gn1, respectively); d R0 within
95 % CI’s of acquisition and clearance rates of USA300 (b3n and gn3, respectively)
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